Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,086 | 2,196 | 6,076 | 11,151 | 20,652 |
| Receivables | N/A | N/A | N/A | N/A | 100 |
| TOTAL | $8,739 | $3,191 | $7,847 | $13,946 | $22,873 |
| Non-Current Assets | |||||
| PPE Net | 72 | 482 | 521 | 560 | 718 |
| TOTAL | $72 | $482 | $521 | $560 | $718 |
| Total Assets | $8,811 | $3,673 | $8,368 | $14,506 | $23,591 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,845 | 1,832 | 1,009 | 1,974 | 2,759 |
| Accrued Expenses | 801 | 2,879 | 2,966 | 2,274 | 3,369 |
| TOTAL | $2,646 | $4,711 | $3,975 | $4,248 | $6,128 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 704 | 4,457 | 4,050 | 5,700 | 15,077 |
| TOTAL | $704 | $4,457 | $4,050 | $5,700 | $15,077 |
| Total Liabilities | $3,350 | $9,168 | $8,025 | $9,948 | $21,205 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,179 | 23,398 | 13,850 | 10,906 | 10,076 |
| Common Shares | 26 | 14 | 12 | 11 | 81 |
| Retained earnings | -442,152 | -434,428 | -424,755 | -418,448 | -418,761 |
| Other shareholders' equity | 0 | 333 | 333 | 333 | 0 |
| TOTAL | $5,461 | $-5,495 | $343 | $4,558 | $2,386 |
| Total Liabilities And Equity | $8,811 | $3,673 | $8,368 | $14,506 | $23,591 |